Literature DB >> 15105812

Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth morphology.

Shinichi Aishima1, Shuji Matsuura, Takahiro Terashi, Kenichi Taguchi, Mitsuo Shimada, Yoshihiko Maehara, Masazumi Tsuneyoshi.   

Abstract

Laminin gamma 2 chain is an extracellular matrix protein that plays an important role in cell migration and tumor invasion. We report altered expression and characteristic localization of this chain in a series of 105 cases of intrahepatic cholangiocarcinomas examined immunohistochemically. All tumors were grossly classified into the following three types: intraductal growth type (n=9), periductal infiltrating type (n=8) and mass-forming type (n=88). The tumors exhibited three distinct staining types: basement membrane staining, cytoplasmic staining and stromal staining. The basement membranous staining of laminin gamma 2 chain was more frequent in biliary dysplasia, intraductal growth and periductal infiltrating type than in mass-forming type. The cytoplasmic staining of carcinoma cells was observed especially at the cancer-stromal interface or at the invasive front of tumors. Stromal staining of laminin gamma 2 chain was essentially localized in the stroma around cancer cells at the invasive area, and the expression was significantly correlated with tumor aggressive factors and a poor prognosis in patients with intrahepatic cholangiocarcinoma. We conclude that laminin gamma 2 chain exhibits aberrant expression in a stepwise manner through different aggressive stages of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105812     DOI: 10.1038/modpathol.3800143

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Laminin-integrin a6b4 interaction activates notch signaling to facilitate bladder cancer development.

Authors:  Nan Hao; Daming Yang; Tianpei Liu; Shucheng Liu; Xinsheng Lu; Libo Chen
Journal:  BMC Cancer       Date:  2022-05-18       Impact factor: 4.638

2.  Gene expression profiling identifies genes predictive of oral squamous cell carcinoma.

Authors:  Chu Chen; Eduardo Méndez; John Houck; Wenhong Fan; Pawadee Lohavanichbutr; Dave Doody; Bevan Yueh; Neal D Futran; Melissa Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

Review 3.  Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms.

Authors:  Alphonse E Sirica; Catherine I Dumur; Deanna J W Campbell; Jorge A Almenara; Olorunseun O Ogunwobi; Jennifer L Dewitt
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

Review 4.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

5.  Role of laminin and cognate receptors in cholangiocarcinoma cell migration.

Authors:  Kittiya Islam; Parichut Thummarati; Pakkanun Kaewkong; Banchob Sripa; Tuangporn Suthiphongchai
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

6.  TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.

Authors:  Hyunseung Sun; Eunmi Kim; Jihye Ryu; Hyejin Lee; Eun-Ae Shin; Minhyeong Lee; Haesong Lee; Jeong-Hoon Lee; Jung-Hwan Yoon; Dae-Geun Song; Semi Kim; Jung Weon Lee
Journal:  Cell Mol Life Sci       Date:  2021-12-18       Impact factor: 9.261

7.  Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.

Authors:  Chantragan Srisomsap; Phannee Sawangareetrakul; Pantipa Subhasitanont; Daranee Chokchaichamnankit; Khajeelak Chiablaem; Vaharabhongsa Bhudhisawasdi; Sopit Wongkham; Jisnuson Svasti
Journal:  J Biomed Biotechnol       Date:  2009-12-27

8.  β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma.

Authors:  Yurie Soejima; Miho Takeuchi; Takumi Akashi; Motoji Sawabe; Toshio Fukusato
Journal:  Int J Mol Sci       Date:  2018-03-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.